A clinical trial to compare atezolizumab plus cabozantinib with cabozantinib alone in people with kidney cancer after checkpoint inhibitor treatment has not worked.

A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment

Cancer
Renal Cell Cancer (RCC)
Renal Cell Carcinoma

Results
Download

Study results

LPS WO41994 CONTACT-03 Interim Results May 2023 English (PDF, 0.4 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 English (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Argentina Spanish (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November2025 Danish (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 French (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 German (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Greek (PDF, 1.2 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Italian (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Japanese (PDF, 1.2 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Korean (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Polish (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Russian (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Spain Spanish (PDF, 1.0 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A clinical trial to compare atezolizumab plus cabozantinib with cabozantinib alone in people with kidney cancer after checkpoint inhibitor treatment has not worked.

Study results

LPS WO41994 CONTACT-03 Interim Results May 2023 English (PDF, 0.4 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 English (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Argentina Spanish (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November2025 Danish (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 French (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 German (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Greek (PDF, 1.2 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Italian (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Japanese (PDF, 1.2 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Korean (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Polish (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Russian (PDF, 1.1 MB)

LPS WO41994 CONTACT-03 Final Results November 2025 Spain Spanish (PDF, 1.0 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

You are about to leave ForPatients

Thank you

Request a call back

Find participating medical centers and current study status in each of them

A clinical trial to compare atezolizumab plus cabozantinib with cabozantinib alone in people with kidney cancer after checkpoint inhibitor treatment has not worked.

For the latest version of this information please go to www.forpatients.roche.com